BUSINESS leaders walk a tight rope of balancing commercial interests with regulatory compliance. On one hand there are shareholders baying for blood when dividends do not improve. Then on the other, you have regulatory authorities waiting to slap you with a hefty fine should you fall foul of any laws. This is a double edged…
Subscribe to read full article. Subscribe today